إعلان
إعلان
DNTH
Dianthus Therapeutics, Inc. Common Stock
38.19
USDبرعاية
+0.11
+0.29%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
قبل الإفتتاح
37.98
-0.21
-0.55%
تقارير أرباح DNTH
النسبة الإيجابية المفاجئة
DNTH تفوق 21 من 30 آخر التقديرات.
70%
التقرير التالي
بيانات التقرير القادم
٠٩ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$406.90K
/-$1.08
التغير الضمني من Q3 25 (Revenue/ EPS)
+2.75%
/+11.34%
التغير الضمني من Q4 24 (Revenue/ EPS)
-59.27%
/+33.33%
Dianthus Therapeutics, Inc. Common Stock earnings per share and revenue
On ٠٥ نوفمبر ٢٠٢٥, DNTH reported earnings of -0.97 USD per share (EPS) for Q3 25, missing the estimate of -0.87 USD, resulting in a -10.28% surprise. Revenue reached 396.00 ألف, compared to an expected 587.93 ألف, with a -32.64% difference. The market reacted with a +8.00% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 16 المحللين forecast an EPS of -1.08 USD, with revenue projected to reach 406.90 ألف USD, implying an زيادة of 11.34% EPS, and زيادة of 2.75% in Revenue from the last quarter.
الأسئلة الشائعة
What were Dianthus Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Dianthus Therapeutics, Inc. Common Stock reported EPS of -$0.97, missing estimates by -10.28%, and revenue of $396.00K, -32.64% below expectations.
How did the market react to Dianthus Therapeutics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 8%, changed from $33.73 before the earnings release to $36.43 the day after.
When is Dianthus Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for ٠٩ مارس ٢٠٢٦.
What are the forecasts for Dianthus Therapeutics, Inc. Common Stock's next earnings report?
Based on 16
المحللين, Dianthus Therapeutics, Inc. Common Stock is expected to report EPS of -$1.08 and revenue of $406.90K for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان